Creative Biolabs-Immuno-oncology

Anti-CD22 (clone 2A10E1) SynExpress E1-mCh-P-B CD4+ T Cells (CAT#: ITS-1124-CR53)

DatasheetDatasheet
Description
This product utilizes CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone 2A10E1). We employs the HBV (EF1α-mCherry-PAX-BamHI) vector components and the SynExpress system of the miRNA Prime Editing/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CD22
Clone
2A10E1
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
mCherry
Promoter
EF1α
Effector Gene
PAX
Insertion Sites
BamHI
Gene Modification
Prime Editing
Modification Domain
miRNA
Carrier Type
HBV
Transformation Accuracy
0.95
Cell Culture
Aseptic Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.